<DOC>
	<DOCNO>NCT02853045</DOCNO>
	<brief_summary>Despite large diffusion generic anti-hypertensive , currently use . Clinical validation study could better convince user prescribers pharmacologic validation . A pragmatic study evaluate generic anti-hypertensive efficacy propose . It take place real condition care hypertensive patient , manometer control criterion . The aim study test hypothesis non-inferiority generic anti-hypertensive blood pressure control .</brief_summary>
	<brief_title>Comparison Blood Pressure Control Achieved Antihypertensive Generic Drugs Moderate Severe Hypertensive Patients</brief_title>
	<detailed_description>List drug : ALDACTONE , FLUMACH , SPIROCTAN , SPIRONONE , FLUDEX , INDATEN , LASILIX , TENSTATEN , ALDACTAZINE , PRINACTIZIDE , SPIROCTAZINE , MODURETIC , AVLOCARDYL , HEMIPRALON , STHASIN , BETATOP , TENORMINE , CELECTOL , DETENSIEL , FELSAN , KERLONE , RAGON , RONALOL , LOPRESSOR , SELOKEN , NEBILOX , TEMERIT , NEVEROL , SECTRAL , ACUITEL , KOREC , BRIEM , CIBACENE , COVERSYL , CAPTOLANE , LOPRIL , FOZITEC , ODRIK , GOPTEN , PRINIVIL , ZESTRIL , RENITEC , TEOULA , ZOFENIL , TRIATEC , KENOMON , ADALATE , CHRONOADALATE , AMLOR , BAYPRESS , DELTAZEN , DILRENE , DIACOR , MONO TILDIEM , FLODIL , IPERTEN , ISOPTINE , LERCAN , ZANIDIP , LEDELCARBERDIPE , LENIBERCARDIPE , DIBERLEPIDINE , XILERMIS , APROVEL , CRISARTERS , IFIRMASTA , FLUPPE , ZELMIRB , ATACAND , KENZEN , KARBIS , COZAAR , LOBERASNAT , LOTANBERSAR , MICARDIS , PRITOR , TOLURA , ZANACODAR , DINORTES , MIRPRESOC , NISIS , TAREG , CUENCA , TIFIVAL , VAGRECOR , VAMADRID , HYPERIUM , PHYSIOTENS , BIPRETERAX , PRETERAX , LODOZ , WYTENS , ACUILIX , KORETIC , BRIAZIDE , CIBADREX , CAPTEA , ECAZIDE , CORENITEC , ENALAVIS , ENALURETIC , COTRIATEC , RADOUCHE , FOZIRETIC , PRINZIDE , ZESTORETIC , COAPROVEL , IFIRMACOMBI , COCRISARTERS , COKENZEN , HYTACAND , COANHYVA , COHESAN , COTAREG , NISISCO , FORTZAAR , HYZAAR , MICARDISPLUS , PRITORPLUS , MARESSI , TOLUCOMBI , TENORDATE , BETA ADALATE</detailed_description>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>hypertensive patient know treat take least two antihypertensive Antihypertension treatment available generic form Absence change antihypertension treatment previous 3 month Patients dialysis Patients cardiac arrhythmia Patient refuse ambulatory blood pressure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>